Merck KGaA raises awareness for smoldering MS symptoms that cause patients to 'unravel'
Recent evidence suggests reducing relapses is “only part of [the] battle” for multiple sclerosis patients, according to Merck KGaA.
While it was previously thought that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.